Cochlear Implants Market - Forecasts from 2018 to 2023

August 2018 | 87 pages | ID: C27C8B62024EN
Knowledge Sourcing Intelligence LLP

Abstracts

The global cochlear implant market was valued at US$1.883 billion in 2017 and is projected to expand at a CAGR of 10.90% over the forecast period to reach US$3.501 billion by 2023. A cochlear implant is a surgically implanted electronic device designed to produce useful hearing sensations to a person with severe to profound nerve deafness by electrically stimulating nerves inside the inner ear. They are designed to help adults and children who get little or no benefit from hearing aids. Increasing awareness among people, advancements in cochlear implants, growing penetration of implants due to an expanded geographical reach of market players and favorable government initiatives are the key drivers boosting the global cochlear implant market growth. The market is expected to grow at a steady pace over the forecast period owing to the rising adoption of advanced cochlear implants among children, strong reimbursement policies of the government. However, risks associated with surgical implant procedure (such as injury to the facial nerve, meningitis, attacks of dizziness or vertigo etc.) and presence of substitute (mouth guard and drugs) are the factors restraining the market growth.
By Type of Fitting
By type of fitting, the global cochlear implant market has been segmented into unilateral and bilateral fitting. Bilateral cochlear implants are growing faster owing to the increasing demand, the ability to recognize the speech in noise, and good reimbursement.
By End-User
By End-User, the global cochlear implant market has been segmented into adults and pediatrics. Cochlear implants for adults dominated the market owing to the presence of a large patient base and lesser complications involved as compared to children.
By Geography
Geographically, the global cochlear implant market has been segmented into North America, Europe, Middle East & Africa, Asia-Pacific, and South America region. Europe accounted for the largest share of all the regions. This can be credited to the high penetration of implants, conductive health infrastructure of the European Union, and presence of a large patient base in the region. The Asia Pacific is anticipated to grow at a fast pace owing to the increasing awareness among people and government support.
Competitive Intelligence
The global key players discussed as a part of the report are Cochlear Ltd., MED-EL, Sonova, Willam Demant Holding A/S, Oticon, Nurotron Biotechnology, and GN Store Nord A/S.

Segmentation

The global cochlear implant market has been analyzed through the following segments:
By Type of Fitting
Unilateral Fitting
Bilateral Fitting
By End User
Adults
Children
By Geography
North America
United States
Canada
Mexico
Others
South America
Brazil
Argentina
Others
Europe
Germany
France
Italy
United Kingdom
Others
Middle East and Africa
Israel
Saudi Arabia
UAE
Others
Asia Pacific
Japan
China
India
Australia
South Korea
Others

Contents

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. GLOBAL COCHLEAR IMPLANT BY TYPE OF FITTING

5.1. Unilateral Fitting
5.2. Bilateral Fitting

6. GLOBAL COCHLEAR IMPLANT BY END USER

6.1. Adults
6.2. Children

7. GLOBAL COCHLEAR IMPLANT GEOGRAPHY

7.1. North America
  7.1.1. United States
  7.1.2. Canada
  7.1.3. Mexico
  7.1.4. Others
7.2. South America
  7.2.1. Brazil
  7.2.2. Argentina
  7.2.3. Others
7.3. Europe
  7.3.1. Germany
  7.3.2. France
  7.3.3. Italy
  7.3.4. United Kingdom
  7.3.5. Others
7.4. Middle East and Africa
  7.4.1. Israel
  7.4.2. Saudi Arabia
  7.4.3. UAE
  7.4.4. Others
7.5. Asia Pacific
  7.5.1. Japan
  7.5.2. China
  7.5.3. India
  7.5.4. Australia
  7.5.5. South Korea
  7.5.6. Others

8. COMPETITIVE INTELLIGENCE

8.1. Recent Deals and Investment
8.2. Strategies of Key Players
8.3. Investment Analysis

9. COMPANY PROFILES

9.1. Cochlear Ltd.
  9.1.1. Company Overview
  9.1.2. Financials
  9.1.3. Products and Services
  9.1.4. Recent Developments
9.2. MED-EL
  9.2.1. Company Overview
  9.2.2. Financials
  9.2.3. Products and Services
  9.2.4. Recent Developments
9.3. Sonova
  9.3.1. Company Overview
  9.3.2. Financials
  9.3.3. Products and Services
  9.3.4. Recent Developments
9.4. William Demant Holding A/S
  9.4.1. Company Overview
  9.4.2. Financials
  9.4.3. Products and Services
  9.4.4. Recent Developments
9.5. Oticon
  9.5.1. Company Overview
  9.5.2. Financials
  9.5.3. Products and Services
  9.5.4. Recent Developments
9.6. Nurotron Biotechnology
  9.6.1. Company Overview
  9.6.2. Financials
  9.6.3. Products and Services
  9.6.4. Recent Developments
9.7. GN Store Nord A/S
  9.7.1. Company Overview
  9.7.2. Financials
  9.7.3. Products and Services
  9.7.4. Recent Developments
*List is not exhaustive
LIST OF FIGURES
LIST OF TABLES